| | | | | | | | | | |
|
|
| Dockets Entered
On July 31, 2007
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
| 1992P-0250
|
| Refrain from action against Genetic Systems HIV-1 test kits
|
|
|
| 1996N-0417
|
| CGMP in Mfg. Packing or Holding Dietary Supplements
|
|
|
| 1998D-1232
|
| Points to consider guidance documents on assayed&unassayed
|
|
|
| 2003N-0573
|
| Draft Animal Cloning Risk Assessment
|
|
|
| 2005D-0112
|
| Guidance for Industry on Clinical Trial Endpoints for the Approval of Cancer Drugs and Biologics
|
|
|
| 2005N-0272
|
| Irradiation in the Production, Processing & Handling of Food
|
|
|
| 2006D-0480
|
| Guidance for Industry
on Complementary & Alternative Medicine Products & Their Regulation
by the Food and Drug Administration
|
|
|
| 2006P-0394
|
| Revise the labeling requirements for eggs sold in the United States
|
|
|
| 2007D-0223
|
| Guidance for Industry on Use of the Computer Crossmatch
|
|
|
| 2007N-0050
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Label Comprehension Study
|
|
|
| 2007N-0204
|
| Joint Meeting of the Gastrointestinal Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee; Notice of Meeting
|
|
|
| 2007N-0217
|
| Licensure of Apheresis Blood Products; Public Workshop
|
|
|
| 2007P-0300
|
| To determine that is suitable for B Braum Medical , Inc. to package a 15% Amino Acid Injection product in a package size not covered under the Reference Listed Drug's (RLD) application
|
|
|
| 1992P-0250
|
| Refrain from action against Genetic Systems HIV-1 test kits
|
|
|
| ACK 1
|
| FDA, DMB
|
| Vol #:
|
| 1
|
|
|
| 1996N-0417
|
| CGMP in Mfg. Packing or Holding Dietary Supplements
|
|
|
| C 260
|
| L. Olson
|
| Vol #:
|
| 43
|
|
|
| C 261
|
| D. Smith
|
| Vol #:
|
| 43
|
|
|
| C 262
|
| D. Olson
|
| Vol #:
|
| 43
|
|
|
| 1998D-1232
|
| Points to consider guidance documents on assayed&unassayed
|
|
|
| EC 1
|
| Spirals of LIfe
|
| Vol #:
|
| 1
|
|
|
| EC 2
|
| Jaw ease
|
| Vol #:
|
| 1
|
|
|
| 2003N-0573
|
| Draft Animal Cloning Risk Assessment
|
|
|
| EMC 734
|
| E. Desipris
|
| Vol #:
|
| 22
|
|
|
| EMC 735
|
| F. Hoffman
|
| Vol #:
|
| 22
|
|
|
| EMC 736
|
| C. Katz
|
| Vol #:
|
| 22
|
|
|
| EMC 737
|
| M. Thrantell
|
| Vol #:
|
| 22
|
|
|
| EMC 738
|
| P. Kremer
|
| Vol #:
|
| 22
|
|
|
| EMC 739
|
| P. Barron
|
| Vol #:
|
| 22
|
|
|
| EMC 740
|
| F. Wiewel
|
| Vol #:
|
| 22
|
|
|
| EMC 741
|
| Form Letter Count 518
|
| Vol #:
|
| 247
|
|
|
| EMC 742
|
| Form Letter Count 14
|
| Vol #:
|
| 248
|
|
|
| EMC 743
|
| Form Letter Count 23
|
| Vol #:
|
| 249
|
|
| | | | | | | | |
|
|
| EC 3
|
| DeGowin Blood Center
|
| Vol #:
|
| 1
|
|
|
| 2007N-0050
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Label Comprehension Study
|
|
|
| EC 4
|
| self
|
| Vol #:
|
| 1
|
|
|
| 2007N-0204
|
| Joint Meeting of the Gastrointestinal Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee; Notice of Meeting
|
|
|
| EC 1
|
| Mr. Gerard Roberts
|
| Vol #:
|
| 1
|
|
|
| EC 2
|
| Northwestern University, Feinberg School of Medici
|
| Vol #:
|
| 1
|
|
|
| EC 3
|
| Miss. Jennifer Meth
|
| Vol #:
|
| 1
|
|
|
| 2007N-0217
|
| Licensure of Apheresis Blood Products; Public Workshop
|
|
|
| EC 1
|
| Regulatory Resources, Inc.
|
| Vol #:
|
| 1
|
|
|
| EC 2
|
| Cascade Regional Blood Services
|
| Vol #:
|
| 1
|
|
|
| EC 3
|
| Mrs. Melanie Rogerson
|
| Vol #:
|
| 1
|
|
|
| EC 4
|
| Gambro BCT
|
| Vol #:
|
| 1
|
|
|
| EC 5
|
| Mr. Richard Robinson
|
| Vol #:
|
| 1
|
|
|
| EC 6
|
| Americas Blood Centers
|
| Vol #:
|
| 1
|
|
|
| 2007P-0300
|
| To determine that is suitable for B Braum Medical , Inc. to package a 15% Amino Acid Injection product in a package size not covered under the Reference Listed Drug's (RLD) application
|
|
|
|
|
|
|
| ACK 1
|
| FDA/ DDM/ to B Braun Medical, Inc.
|
| Vol #:
|
| 1
|
|
|
| CP 1
|
| B Braun Medical, Inc.
|
| Vol #:
|
| 1
|
|